Ronald A. Paulus, MD, is Catalyst Advisor with General Catalyst and a Senior Scholar in the Stanford Clinical Excellence Research Center. He also serves as President and CEO of RAPMD Strategic Advisors, providing advisory services to health system Boards, CEOs and tech companies and as President of Maribel Health, a General Catalyst company with a mission to make the home the center of the health system. In addition, he has held numerous Board positions, including: CoverMyMeds, Karius, Mercy, Olive, Ossium Health and PathAI.
Dr. Paulus was the immediate past President and CEO of Mission Health, a $2 billion integrated health system serving all of western North Carolina -- a region older, poorer, sicker and less likely to be insured than state and national averages. Mission Health included: six general acute care hospitals (including four Critical Access Hospitals), a rehabilitation hospital, more than five hundred employed providers, inpatient and home hospice programs, a PACE program and an MSSP Accountable Care Organization comprised of more than 1,000 physicians in a region-wide clinically-integrated network. Mission joined HCA Healthcare (HCA) in February 2019.
During his tenure, Mission Health reduced inpatient mortality by more than half, achieved six-sigma medication safety results, improved patient experience to above the 90tpercentile, doubled employee engagement scores to more than twice the national average and became the only health system ever designated as one of the nation’s Top 15 Health Systems for six of seven six years (IBM Watson Health, 2012-2018) performing in the top 2% of the United States in the last award period. Mission Health closed a transformative transaction with HCA on February 1, 2019 creating the largest per capita Foundation in America. The new $1.7+ billion Dogwood Health Trust is dedicated to impacting the social determinants of health to dramatically improve the health and wellbeing of all peoples and communities in western North Carolina.
Before joining Mission Health, Dr. Paulus was Executive Vice President, Clinical Operations and Chief Innovation Officer for Geisinger Health System, where he managed Geisinger’s hospitals and its more than 800 physician member group practice and also was responsible for ensuring system-wide innovation. Prior to joining Geisinger, Dr. Paulus was co-founder, President and later CEO of CareScience, Inc. (a NASDAQ company), later acquired by Premier, Inc. (NASDAQ: PINC;) providing an analytics platform to support health systems’ quality and efficiency improvement work used today by nearly 1,000 hospitals nationwide.
Dr. Paulus received his MD degree from The School of Medicine, University of Pennsylvania, and his MBA, concentration in healthcare management, and BS in Economics from The Wharton School, University of Pennsylvania. He has published peer-reviewed book chapter and journal articles (including in the Annals of Internal Medicine, New England Journal of Medicine and Health Affairs), and speaks regularly on the topics of health care quality and efficiency, innovation, physician and health system leadership and new models of care. Dr. Paulus has testified before both the US House (on the 340b Drug Program) and the US Senate (the Stark and anti-kickback laws) and he has been named one of Modern Healthcare’s Top 50 Most Influential Physician Executives and Leaders several times, and was recently among the Top 15 on that list.